التفاصيل البيبلوغرافية
| العنوان: |
Effect of early metoprolol before PCI in ST‐segment elevation myocardial infarction on infarct size and left ventricular ejection fraction. A systematic review and meta‐analysis of clinical trials. |
| المؤلفون: |
Motawea, Karam R., Gaber, Hamed, Singh, Ravi B., Swed, Sarya, Elshenawy, Salem, Talat, Nesreen Elsayed, Elgabrty, Nawal, Shoib, Sheikh, Wahsh, Engy A., Chébl, Pensée, Reyad, Sarraa M., Rozan, Samah S., Aiash, Hani |
| المصدر: |
Clinical Cardiology; Oct2022, Vol. 45 Issue 10, p1011-1028, 18p |
| مصطلحات موضوعية: |
ST elevation myocardial infarction, VENTRICULAR ejection fraction, MYOCARDIAL infarction, METOPROLOL, PERCUTANEOUS coronary intervention |
| مستخلص: |
Aim: This meta‐analysis aims to look at the impact of early intravenous Metoprolol in ST‐segment elevation myocardial infarction (STEMI) before percutaneous coronary intervention (PCI) on infarct size, as measured by cardio magnetic resonance (CMR) and left ventricular ejection fraction. Methods: We searched the following databases: PubMed, Scopus, Cochrane library, and Web of Science. We included only randomized control trials that reported the use of early intravenous Metoprolol in STEMI before PCI on infarct size, as measured by CMR and left ventricular ejection fraction. RevMan software 5.4 was used for performing the analysis. Results: Following a literature search, 340 publications were found. Finally, 18 studies were included for the systematic review, and 8 clinical trials were included in the meta‐analysis after the full‐text screening. At 6 months, the pooled effect revealed a statistically significant association between Metoprolol and increased left ventricular ejection fraction (LVEF) (%) compared to controls (mean difference [MD] = 3.57, [95% confidence interval [CI] = 2.22–4.92], p <.00001), as well as decreased infarcted myocardium(g) compared to controls (MD = −3.84, [95% [CI] = −5.75 to −1.93], p <.0001). At 1 week, the pooled effect revealed a statistically significant association between Metoprolol and increased LVEF (%) compared to controls (MD = 2.98, [95% CI = 1.26−4.69], p =.0007), as well as decreased infarcted myocardium(%) compared to controls (MD = −3.21, [95% CI = −5.24 to −1.18], p =.002). Conclusion: A significant decrease in myocardial infarction and increase in LVEF (%) was linked to receiving Metoprolol at 1 week and 6‐month follow‐up. [ABSTRACT FROM AUTHOR] |
|
Copyright of Clinical Cardiology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder